Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Organic Letters|January 17, 2003
ROMP-generated oligomeric sulfonyl chlorides as versatile soluble scavenging agentsJoel D Moore, Russell H Herpel, Joy R Lichtsinn, et al.
Journal of the American Chemical Society|January 6, 2005
Multipolymer solution-phase reactions: application to the Mitsunobu reactionAndrew M Harned, Helen Song He, Patrick H Toy, et al.
Molecular Cancer Therapeutics|May 5, 2021
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic MastocytosisAnu Gupta, Jarnail Singh, Alfonso García-Valverde, et al.
The Journal of Organic Chemistry|October 22, 2008
High-load, oligomeric dichlorotriazine: a versatile ROMP-derived reagent and scavengerAlan Rolfe, Donald A Probst, Kelly A Volp, et al.
Neoplasia (New York, N.Y.)|January 20, 2011
Targeted inhibition of multiple receptor tyrosine kinases in mesotheliomaWen-Bin Ou, Christopher Hubert, Joseph M Corson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast CancerJesus D Anampa, Daniel L Flynn, Cynthia Leary, et al.
Journal of Medicinal Chemistry|February 3, 2006
Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonistsDaniel P Becker, Daniel L Flynn, Alan E Moormann, et al.
Organic Letters|December 3, 2010
Monomer-on-monomer (MoM) Mitsunobu reaction: facile purification utilizing surface-initiated sequestrationPradip K Maity, Alan Rolfe, Thiwanka B Samarakoon, et al.
Elife|August 30, 2024
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancerPhaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, et al.
Pageof 4